Funding for this research was provided by:
Text and Data Mining valid from 2020-03-23
Received: 8 November 2019
Accepted: 31 January 2020
First Online: 23 March 2020
Ethics approval and consent to participate
: The clinical trial (EudraCT 2012-005228-14 and NCT01858116) was approved by the Regional Ethics Review Board in Uppsala (Dnr 2012/554), Radiation Protection Ethics Committee (Dnr D13/01), and Swedish Medical Products Agency (Dnr 151:2012/121491) [CitationRef removed]. All patients signed informed consent before inclusion in the study.
: All patients signed informed consent for publication before inclusion in the study.
: The authors declare that they have no competing interests.